Jialiang Brain Science Showcases Core Epilepsy Technologies at the 11th CAAE International Epilepsy Forum
GenLight
Innovative Medical Device Solution Provider
Peak Summit: Jointly Drawing a New Blueprint for Epilepsy Diagnosis and Treatment
From October 24 to 26, 2025, the 11th CAAE International Epilepsy Forum was successfully held under much anticipation. The "CAAE International Epilepsy Forum" is a biennial academic conference hosted by the China Association Against Epilepsy (CAAE). It serves as an important platform for authoritative experts in the field of epilepsy from both within and outside China to share cutting-edge information and exchange academic achievements, shouldering the responsibility of leading the development of epilepsy disciplines in China.
At this academic feast featuring intense collisions of thought and wisdom, GenLight showcased its innovative epilepsy solutions, engaging in in-depth exchanges with experts in China. This demonstrated its hardcore strength and firm commitment on the path to overcoming the complex disease of epilepsy.
GenLight Highlights: Innovative Technology Draws Attention
During the exhibition and exchange session of this forum, Genlight Neurotech showcased the company's latest products and technological achievements in the field of epilepsy:LaserRO™ MRI-Guided Laser Ablation Minimally Invasive Surgical System、Epilcure™ Implantable Closed-Loop Self-Responsive Neurostimulation System、S-Deep™ Intracranial Deep Electrode, and exchanged valuable opinions with many experts, scholars, and industry professionals on topics such as the clinical application experience and future development trends of related technologies.
Expert Communication
Refractory epilepsy has imposed a heavy burden on tens of millions of patients and their families worldwide. Since its establishment, Genlight Neurotech has been focusing on the development of cutting-edge technologies in the field of neurosurgery, committed to providing doctors with more advanced surgical tools and offering patients more effective and safer treatment options.
The excellent presentation at the CAAE International Epilepsy Forum marked a concentrated review of Genlight Neurotech's阶段性成果. We are fully aware that the road to conquering epilepsy is long and arduous. In the future, Genlight Neurotech will continue to uphold the core concept of "Innovation-driven, patient-centered," increase R&D investment, deepen medical-engineering collaboration, and promote more China-originated high-end medical devices to enter the market and serve clinical needs.
